Format

Send to

Choose Destination
J Behav Med. 2015 Oct;38(5):715-26. doi: 10.1007/s10865-015-9642-5. Epub 2015 May 24.

Perceived ambiguity as a barrier to intentions to learn genome sequencing results.

Author information

1
National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892-9761, USA. Jennifer.taber@nih.gov.
2
National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892-9761, USA.
3
Maine Medical Center, Portland, ME, USA.
4
National Human Genome Research Institute, Bethesda, MD, USA.

Abstract

Many variants that could be returned from genome sequencing may be perceived as ambiguous-lacking reliability, credibility, or adequacy. Little is known about how perceived ambiguity influences thoughts about sequencing results. Participants (n = 494) in an NIH genome sequencing study completed a baseline survey before sequencing results were available. We examined how perceived ambiguity regarding sequencing results and individual differences in medical ambiguity aversion and tolerance for uncertainty were associated with cognitions and intentions concerning sequencing results. Perceiving sequencing results as more ambiguous was associated with less favorable cognitions about results and lower intentions to learn and share results. Among participants low in tolerance for uncertainty or optimism, greater perceived ambiguity was associated with lower intentions to learn results for non-medically actionable diseases; medical ambiguity aversion did not moderate any associations. Results are consistent with the phenomenon of "ambiguity aversion" and may influence whether people learn and communicate genomic information.

KEYWORDS:

Ambiguity aversion; Genetic/genome testing; Optimism; Perceived ambiguity; Response efficacy; Tolerance for uncertainty

PMID:
26003053
PMCID:
PMC4568142
DOI:
10.1007/s10865-015-9642-5
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center